ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)
| Autor: | Redelman-Sidi, G., Michielin, O., Cervera, C., Ribi, C., Aguado, J.M., Fernández-Ruiz, M., Manuel, O. |
|---|---|
| Zdroj: | In Clinical Microbiology and Infection June 2018 24 Supplement 2:S95-S107 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|